| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash from (used in) investing activities | -284 | 0 |
| Repayment of long-term debt | 0 | 0 |
| Proceeds from employee stock purchase plan and stock option exercises | 394 | 394 |
| Net cash from (used in) financing activities | 394 | 394 |
| Change in cash and cash equivalents | 22,185 | 10,443 |
| Cash and cash equivalents at beginning of period | 14,936 | - |
| Cash and cash equivalents at end of period | 37,121 | - |
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)